.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Hydralazine hydrochloride; hydrochlorothiazide - Generic Drug Details

« Back to Dashboard
Hydralazine hydrochloride; hydrochlorothiazide is the generic ingredient in twenty-one branded drugs marketed by Superpharm, Solvay, Novartis, Watson Labs, Par Pharm, Ivax Pharms, Lederle, Sun Pharm Inds, Sandoz, Ivax Sub Teva Pharms, Mylan, and Tg United Labs, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for hydralazine hydrochloride; hydrochlorothiazide.

Summary for Generic Name: hydralazine hydrochloride; hydrochlorothiazide

Tradenames:21
Patents:0
Applicants:12
NDAs:36
Drug Master File Entries: see list19
Bulk Api Vendors: see list1
Clinical Trials: see list1,079
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hydralazine hydrochloride; hydrochlorothiazide at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Pharms
HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50
hydralazine hydrochloride; hydrochlorothiazide
CAPSULE;ORAL088358-001Apr 10, 1984DISCNNoNo► subscribe► subscribe
Novartis
SER-AP-ES
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL012193-005Approved Prior to Jan 1, 1982DISCNNoNo► subscribe► subscribe
Watson Labs
HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE
hydralazine hydrochloride; hydrochlorothiazide; reserpine
TABLET;ORAL085771-001Approved Prior to Jan 1, 1982DISCNNoNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc